Correlation Between XSpray Pharma and AcouSort
Can any of the company-specific risk be diversified away by investing in both XSpray Pharma and AcouSort at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XSpray Pharma and AcouSort into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XSpray Pharma AB and AcouSort AB, you can compare the effects of market volatilities on XSpray Pharma and AcouSort and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XSpray Pharma with a short position of AcouSort. Check out your portfolio center. Please also check ongoing floating volatility patterns of XSpray Pharma and AcouSort.
Diversification Opportunities for XSpray Pharma and AcouSort
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between XSpray and AcouSort is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding XSpray Pharma AB and AcouSort AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AcouSort AB and XSpray Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XSpray Pharma AB are associated (or correlated) with AcouSort. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AcouSort AB has no effect on the direction of XSpray Pharma i.e., XSpray Pharma and AcouSort go up and down completely randomly.
Pair Corralation between XSpray Pharma and AcouSort
If you would invest (100.00) in XSpray Pharma AB on April 24, 2025 and sell it today you would earn a total of 100.00 from holding XSpray Pharma AB or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
XSpray Pharma AB vs. AcouSort AB
Performance |
Timeline |
XSpray Pharma AB |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
AcouSort AB |
XSpray Pharma and AcouSort Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with XSpray Pharma and AcouSort
The main advantage of trading using opposite XSpray Pharma and AcouSort positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XSpray Pharma position performs unexpectedly, AcouSort can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AcouSort will offset losses from the drop in AcouSort's long position.XSpray Pharma vs. Xbrane Biopharma AB | XSpray Pharma vs. Hansa Biopharma AB | XSpray Pharma vs. Cantargia AB | XSpray Pharma vs. Vicore Pharma Holding |
AcouSort vs. Xbrane Biopharma AB | AcouSort vs. Hansa Biopharma AB | AcouSort vs. Cantargia AB | AcouSort vs. Vicore Pharma Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
CEOs Directory Screen CEOs from public companies around the world |